Brevan Howard Capital Management LP Tyra Biosciences, Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 31,101 shares of TYRA stock, worth $483,309. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,101
Previous 36,594
15.01%
Holding current value
$483,309
Previous $350,000
24.29%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TYRA
# of Institutions
115Shares Held
58.4MCall Options Held
23.5KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA12.2MShares$190 Million2.93% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$63.4 Million95.15% of portfolio
-
Nextech Invest Ag4.06MShares$63 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$63 Million8.64% of portfolio
-
Bvf Inc San Francisco, CA3.65MShares$56.7 Million2.76% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $652M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...